{"schema":"hottub-news/list/v1","item_schema":"hottub-news/item/v1","count":2,"sponsored":0,"items":[{"id":"n_zcj3kdzmhnc3skkuazaa","seq":1535615,"kind":"article","title":"Analyzing Fate Therapeutics (NASDAQ:FATE) and Syndax Pharmaceuticals (NASDAQ:SNDX)","url":"https://www.themarketsdaily.com/2026/10/03/analyzing-fate-therapeutics-nasdaqfate-and-syndax-pharmaceuticals-nasdaqsndx.html","published":"2026-10-03T13:06:23Z","seen":"2026-10-03T13:06:23Z","lang":"en","source":{"id":"themarketsdaily.com","name":"themarketsdaily.com","domain":"themarketsdaily.com"},"via":"gdelt-gkg-english","topics":["economy","business","health"],"authors":["Tristan Rich"],"entities":[{"id":"Q30287119","name":"Fate Therapeutics","type":"org"},{"id":"Q112085354","name":"Syndax Pharmaceuticals","type":"org"}],"story":"st_zcj3kdzmhnc3skkuazaa","category":"economy-business","category_p":0.59,"sentiment":"neutral","tone":0.46,"political":0.02},{"id":"n_qnaiclxswpaal3faac7q","seq":1422257,"kind":"press_release","title":"Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://www.globenewswire.com/news-release/2026/10/02/3374004/0/en/syndax-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4.html","summary":"NEW YORK, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on October 1, 2026, the Company granted inducement awards to purchase up to 213,300 shares of common stock to nine new employees under the Company's 2023 Inducement Plan. The stock options will vest over four years, with 25% of the underlying shares vesting on the one-year anniversary of…","published":"2026-10-02T20:01:00Z","seen":"2026-10-02T20:05:10Z","lang":"en","source":{"id":"globenewswire-public","name":"GlobeNewswire — public companies","domain":"globenewswire.com","outlet":{"wikidata":"Q5570956","name":"GlobeNewswire","type":"other","country":"US","designations":["business","press release distributor"]}},"via":"globenewswire-public","topics":["business","nasdaq:sndx","us87164f1057"],"entities":[{"id":"Q112085354","name":"Syndax Pharmaceuticals","type":"org"}],"story":"st_b4wvtkclozu3hzn3nmqq","category":"economy-business","category_p":0.63,"sentiment":"neutral","tone":0.16,"political":0.12}]}